Gentian Diagnostics: Key information relating to the proposed cash dividend

12 Feb 2026 09:49 CET

Moss, 12 February 2026

The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK
0.60 per
share, based on the company's financial statements for the financial year 2025,
to the General Meeting.

Dividend amount: 0.60 per share
Announced currency: Norwegian krone (NOK)
Last day including right: 5 May 2026
Ex-date: 6 May 2026
Record date: 7 May 2026
Payment date: from 18 May 2026
Date of approval: 5 May 2026


For further information, please contact:

Njaal Kind, CFO
njaal.kind@gentian.no
+47 919 06 525 (mobile)

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site